HIGHFDA DRUG

Sandoz/Cardinal Health Enoxaparin Sodium Injection Recall Over Mispacked Bags

Enoxaparin Sodium Injection recall active as of 2025. Cardinal Health and Sandoz Inc. distributed the product in Kansas. Bags labeled 80 mg/0.8 mL contained 30 mg/0.3 mL doses. Health authorities urge immediate stop-use and guidance from providers.

Official notice
ENOXAPARIN SODIUMCardinal Health 107, LLCSandoz IncHealth & Personal CareDrugs & MedicationsOuter package - NDC 55154-3543-5Inner label - NDC 0781-3238-01Lot SAD08033AA

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 5, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 5, 2025
Hazard Level
HIGH
Brands
ENOXAPARIN SODIUM, Cardinal Health 107, LLC, Sandoz Inc
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
ENOXAPARIN SODIUM, Cardinal Health 107, LLC, Sandoz Inc
Product type
Enoxaparin Sodium Injection
Model numbers
Outer package - NDC 55154-3543-5, Inner label - NDC 0781-3238-01, Lot SAD08033AA, Lot SAF13211A
UPC codes
55154-3540, 55154-3541, 55154-3542, 55154-3543, 55154-3544, 0781-3238, 0781-3246, 0781-3256 +12 more
Sizes
0.3 mL
Sold at
Unknown
Where affected
KS

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 5, 2025

  2. Reported by FDA DRUG

    September 3, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Cardinal Health Inc. or your healthcare provider for guidance. Notification method: Letter

About This Product

Enoxaparin Sodium Injection is an anticoagulant used to prevent and treat deep vein thrombosis and pulmonary embolism. It is administered by healthcare professionals.

Why This Is Dangerous

Mislabeled bags could result in incorrect dosing, potentially causing under-anticoagulation or over-anticoagulation with risk of bleeding.

Industry Context

This recall is not stated as part of a broader industry pattern.

Real-World Impact

Immediate action required for clinicians and patients using affected lots; risk to patient safety if incorrect dose is administered.

Practical Guidance

How to identify if yours is affected

  1. Verify outer label NDC 55154-3543-5.
  2. Verify inner label NDC 0781-3238-01.
  3. Check Lot numbers SAD08033AA or SAF13211A.

Where to find product info

FDA enforcement page for D-0597-2025; recall letters from Cardinal Health and Sandoz.

What timeline to expect

Refund/replacement processes follow agency guidance in recall letters; timeline varies by institution.

If the manufacturer is unresponsive

  • Escalate to hospital risk management
  • File a complaint with FDA if provider unresponsive

How to prevent similar issues

  • Always verify NDCs before administration
  • Use serials to track lots
  • Follow hospital protocol for drug recalls

Documentation advice

Keep recall letter, log lot numbers, capture communications with supplier and pharmacy

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Enoxaparin Sodium Injection, USP, 30 mg/0.3 mL. Packaging: 0.3 mL prefilled syringes in bags of 5. Outer label NDC 55154-3543-5. Inner label NDC 0781-3238-01. Distributor: Cardinal Health Inc. and Sandoz Inc. Route: Rx Only.

Reported Incidents

No injuries or incidents have been reported in the recall notice.

Key Facts

  • 20 bags affected? (quantity field indicates 10 bags in description)
  • High hazard due to dosing mislabeling
  • Lot numbers: SAD08033AA, SAF13211A

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANTPREGNANTPREGNANT
Injury Types
ELECTRICALLACERATIONPOISONINGOTHER

Product Details

Model Numbers
Outer package - NDC 55154-3543-5
Inner label - NDC 0781-3238-01
Lot SAD08033AA
Lot SAF13211A
UPC Codes
55154-3540
55154-3541
55154-3542
+17 more
Affected States
KS
Report Date
September 3, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more